Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Adipokines, Inflammation, and Metabolic Diseases, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health, and Atherosclerosis and Cardiovascular Diseases.
Validation of an assay for NGAL in a pediatric population.
Soluble C5b-9 (sC5b-9) in Pediatrics-A Clinical Assessment.
Pediatric case of hemoglobin I-high Wycombe variant.
Path Towards Biopsy-Free Diagnosis of Celiac Disease in Pediatric Patients.
Pediatric vitamin D: Pseudo-hypervitaminosis.
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
Interference of eltrombopag with bilirubin measurements on the Vitros 5600 analyzer.
Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut–Brain Axis
Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects
Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors
Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes
Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity
Suppression of Ghrelin Exacerbates HFCS-Induced Adiposity and Insulin Resistance
Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial
Regulation of Inflammatory Phenotype in Macrophages by a Diabetes-Induced Long Noncoding RNA
The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia
Coenzyme Q10 Benefits Symptoms in Gulf War Veterans: Results of a Randomized Double-Blind Study
The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes
Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo
Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome